Medical

Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor

WSW, NY, 23rd July 2026, FinanceWire … Read More

What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity

WSW, NY, 22nd July 2026, FinanceWire … Read More

PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential

WSW, NY, 21st July 2026, FinanceWire … Read More

Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)

WSW, NY, 16th July 2026, FinanceWire … Read More

Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)

WSW, NY, 16th July 2026, FinanceWire … Read More

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

WSW, NY, 15th July 2026, FinanceWire … Read More

Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That

WSW, NY, 14th July 2026, FinanceWire … Read More

The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush

WSW, NY, 9th July 2026, FinanceWire … Read More

Behavioral Health Experts Report Growing Interest in Couples-Focused Addiction Treatment

SAN DIEGO, California, 3rd July 2026, FinanceWire … Read More

Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)

WSW, NY, 2nd July 2026, FinanceWire … Read More